Last week was favorable for Wall Street with the S&P 500, the Dow Jones and the Nasdaq returning about 3%, 2.2% and 6.1%, respectively. Hopes of American businesses reopening, moderation in new virus cases and chances of treatment coming on stream kept markets in the positive territory.
However, if investors can identify the trending investing area amid all this coronavirus chaos, they can easily take a leveraged position on that and book sturdy profits in a short span.
Keeping this in mind, below we highlight a few leveraged ETF areas that were among the toppers last week.
FANG+
The NYSE FANG+ Index includes 10 highly liquid stocks that make up a segment of the technology and consumer discretionary sectors consisting of highly traded growth stocks of technology and tech-enabled companies. These stocks are Facebook (NASDAQ:FB), Apple (NASDAQ:AAPL), Amazon (NASDAQ:AMZN), Netflix (NASDAQ:NFLX), Alphabet (NASDAQ:GOOGL), Alibaba (NYSE:BABA), Baidu (NASDAQ:BIDU), Nvidia, Tesla (NASDAQ:TSLA) and Twitter.
These stocks have been rallying lately as the coronavirus fear has charged up the tech and Internet sector. Global lockdowns have left people binge-watching and benefited media-services provider and production company Netflix. At the same time, widespread work-and-learn-from-home has favored cloud businesses of Microsoft (NASDAQ:MSFT), Amazon, Apple and Alphabet. Also, Amazon and Alibaba gained from online shopping.
As a result, MicroSectors FANG+ Index 3X Inverse Leveraged ETN FNGU (up 35%) and MicroSectors FANG+ Index 2X Leveraged ETN FNGO (up 22.8%) were the winners last week.
Biotech
Stocks of medical companies that make testing kits and are developing the treatment and vaccine to fight COVID-19 have gained immensely this year. Gilead Sciences (NASDAQ:GILD)’ GILD antiviral medicine remdesivir has been receiving positive response in clinical trials in some COVID-19 patients. Plus, Abbott ABT has launched its third COVID-19 test.
Then there are health-care giants like Johnson & Johnson (NYSE:JNJ) JNJ which are trying to come up with a vaccine. Pfizer Inc. (NYSE:PFE) PFE too informed about its plan to support the development and distribution of BioNTech SE’s BNTX COVID-19 vaccine candidate.Then there is Sanofi (PA:SASY) SNY, which in collaboration with BARDA, is working to test a preclinical vaccine candidate using its recombinant DNA platform (read: Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress).
Naturally, funds like Direxion Daily S&P Biotech Bull 3x Shares LABU (up 30.2%) and Direxion Daily Healthcare Bull 3x Shares CURE (up 18.8%) had every reason to rally last week.
Semiconductor
Last week was full of good news for the chip space. Samsung (KS:005930) announced that it has teamed up with chipmaker Xilinx’s adaptive compute acceleration platform (ACAP) for 5G deployments. Then Taiwan Semiconductor Manufacturing’s TSM shares gained on better-than-expected first-quarter results. The chip maker’s guidance for the second quarter was also upbeat.
Chinese regulators approved Nvidia’s NVDA $6.9 billion acquisition of high-performance interconnect provider Israel-based Mellanox, announced in March 2019. The acquisition is likely to be immediately accretive to NVIDIA’s non-GAAP gross margin, non-GAAP EPS and free cash flow. European regulators cleared the buyout in December.
If these were not enough, could computing — a hot area in the coronavirus-stricken economy —has been driving demand for chips. Direxion Daily Semiconductor Bull 3x Shares SOXL added 18.8% last week.
Consumer Discretionary
The impending reopening of the U.S. economy as well as the massive Fed and U.S. government stimulus has given the sector a fresh lease of life. Direxion Daily Consumer Discretionary Bull 3X Shares WANT gained 17.3% last week. The underlying index of the fund is heavy on Amazon (23.6%), followed by Home Depot (NYSE:HD) (9.88%), McDonald’s (NYSE:MCD) (6.18%), Nike (NYSE:NKE) (5.24%) and Starbucks (NASDAQ:SBUX) (4.31%).
Consumer Staples
Though America is planning a reopening, a return to complete normalcy will take time as reopening varies from state to state and comes with certain conditions. So, investors can expect panic buying of essential items to remain in place for a few more weeks, if the situation does not worsen. Probably because of this reason, Direxion Daily Consumer Staples Bull 3X Shares NEED (11.5%) fared better last week (read: 2 Agricultural ETFs Benefit From the Coronavirus Scare).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson & Johnson (JNJ): Free Stock Analysis Report
NVIDIA Corporation (NASDAQ:NVDA): Free Stock Analysis Report
Sanofi (SNY): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Stock Analysis Report
Gilead Sciences, Inc. (GILD): Free Stock Analysis Report
Abbott Laboratories (NYSE:ABT): Free Stock Analysis Report
Taiwan Semiconductor Manufacturing Company Ltd. (TSM): Free Stock Analysis Report
Direxion Daily S&P Biotech Bull 3X Shares (LABU): ETF Research Reports
Direxion Daily Semiconductor Bull 3X Shares (SOXL): ETF Research Reports
Direxion Daily Healthcare Bull 3x Shares (CURE): ETF Research Reports
Direxion Daily Consumer Discretionary Bull 3X Shares (WANT): ETF Research Reports
Direxion Daily Consumer Staples Bull 3X Shares (NEED): ETF Research Reports
MicroSectors FANG+ Index 3X Leveraged ETN (FNGU): ETF Research Reports
MicroSectors FANG+ Index 2X Leveraged ETN (FNGO): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report